Protein S deficiency D68.5

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Protein S defect

Definition
This section has been translated automatically.

Autosomal-dominantly inherited (analogous to protein C deficiency) or acquired disease associated with reduced fibrinolytic activity and an increased risk of thrombosis due to a lack of protein S. In the hereditary form, mutations in the protein S-alpha gene (PROS1 gene) are present. Up to now > 100 different mutations in the PROS1 gene have been described.

Classification
This section has been translated automatically.

The protein S deficiency is divided into 3 groups:

  • Type I: The activity and the total and free antigen (concentration) are reduced.
  • Type II: The activity is reduced, free and total antigen are normal.
  • Type III: The activity as well as the free antigen are reduced, the total antigen is normal (C4B binding protein is increased.

Occurrence/Epidemiology
This section has been translated automatically.

The prevalence in the normal population is approx. 0.03 - 0.13%; in patients with thrombophilia (increased tendency to thrombosis) it is 5 - 15%.

Etiopathogenesis
This section has been translated automatically.

Protein S is a vitamin K-dependent plasma protein that acts as a cofactor in the activation of protein C. Protein S alone has no influence on a clotting process. Together in complex with Protein C, Protein S accelerates the effect of Protein C due to its extremely high affinity for negatively charged phospholipid surfaces. 60% of the protein S in plasma is bound to the complement binding protein C. 40% circulate in free form. The free and the bound form can be determined separately. Heterozygous deficiencies are detectable in 2-5% of thrombosis patients.

In addition to hereditary deficiency, protein S deficiency can also be caused by exogenous factors:

  • Liver diseases, so that synthetic weakness
  • Waste in acute respiratory distress syndrome (ARDS)
  • Cirrhosis of the liver
  • Coumarin therapy
  • Asparaginase therapy
  • Consumption coagulopathy
  • Sepsis
  • Chronic inflammatory bowel disease
  • Viral infections.

Manifestation
This section has been translated automatically.

Congenital protein S deficiency is an autosomal-dominant inherited disease (analogous to protein C deficiency) that is associated with a significantly increased risk of thrombosis. Mutations in the protein S-alpha gene (PROS1 gene) are present. Up to now > 100 versch. mutations in the PROS1 gene have been described.

Note(s)
This section has been translated automatically.

The molecular weight of the protein S is 69,000 D. The plasma concentration of the total protein is 20-25 mg/l or 60-120%. The free protein S is 7-10 mg/l, corresponding to an activity of 23-49 mg/l of the total protein. The half-life is 42.5 hours. Apart from the liver, synthesis takes place in the endothelium and megakaryocytes.

Literature
This section has been translated automatically.

  1. HA Neumann (2014) The coagulation system. ABW Scientific Publisher GmbH Berlin S. 220f

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 29.10.2020